| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,175,500 | 1,175,500 | 1,149,000 | 1,137,500 | 1,006,400 |
|
Cost of Revenue
|
-720,600 | -720,600 | -709,700 | -705,200 | -648,200 |
|
Gross Profit
|
454,900 | 454,900 | 439,300 | 432,300 | 358,200 |
| Selling, General and Administrative Expenses
|
-254,100 | -254,100 | -258,200 | -254,600 | -229,800 |
| Other Income/Expense, Operating
|
-- | -- | -- | 0 | 3,800 |
|
Operating Income/Expenses
|
-254,100 | -254,100 | -258,200 | -254,600 | -226,000 |
|
Total Operating Profit/Loss
|
200,800 | 200,800 | 181,100 | 177,700 | 132,200 |
| Total Net Finance Income/Expense
|
-17,300 | -17,300 | -18,400 | -26,300 | -19,800 |
| Irregular Income/Expenses
|
-1,600 | -1,600 | -1,400 | 0 | 0 |
|
Non-Operating Income/Expenses, Total
|
-18,900 | -18,900 | -19,800 | -26,300 | -19,800 |
|
Pretax Income
|
181,900 | 181,900 | 161,300 | 151,400 | 112,400 |
| Provision for Income Tax
|
-45,300 | -45,300 | -36,400 | -38,900 | -20,800 |
|
Net Income from Continuing Operations
|
136,600 | 136,600 | 124,900 | 112,500 | 91,600 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
136,600 | 136,600 | 124,900 | 112,500 | 91,600 |
|
Net Income after Non-Controlling/Minority Interests
|
136,600 | 136,600 | 124,900 | 112,500 | 91,600 |
|
Net Income Available to Common Stockholders
|
136,600 | 136,600 | 124,900 | 112,500 | 91,600 |
|
Diluted Net Income Available to Common Stockholders
|
136,600 | 136,600 | 124,900 | 112,500 | 91,600 |
|
Common Dividend per Share
|
0.03 | 0.03 | 0.03 | 0.02 | 0.01 |
| Basic EPS
|
0.16 | 0.16 | 0.14 | 0.13 | 0.11 |
| Diluted EPS
|
0.15 | 0.15 | 0.14 | 0.13 | 0.10 |
|
Basic Weighted Average Shares Outstanding
|
872,500 | 872,500 | 874,400 | 862,400 | 861,200 |
|
Diluted Weighted Average Shares Outstanding
|
882,200 | 882,200 | 885,200 | 883,500 | 880,700 |
|
Reported Normalized Basic EPS
|
0.16 | 0.16 | 0.14 | 0.14 | 0.13 |
|
Reported Normalized Diluted EPS
|
0.16 | 0.16 | 0.14 | 0.13 | 0.13 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
199,600 | 199,600 | 180,900 | 176,400 | 131,400 |
|
EBITDA
|
247,100 | 247,100 | 226,800 | 221,700 | 176,900 |
|
Normalized EBITDA
|
226,900 | 226,900 | 213,200 | 201,600 | 182,300 |
|
Normalized Income
|
137,700 | 137,700 | 127,000 | 118,400 | 111,100 |
|
Total Unusual Items
|
9,000 | 9,000 | 6,600 | 26,300 | 30,800 |
3/31/2023 - 6/25/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade